MHRA’s regulation covering decentralized manufacturing to come into effect Blog & Article 19th August 2025
Contamination Control Strategies for ATMP Manufacturing: A PharmaLex Perspective Journal Article 19th August 2025
Regulatory case study: Outsourcing excellence drives growth for specialty pharmaceutical developer Case Study
Local Contact Francois De Witte Chief Financial Officer PharmaLex Belgium Rue Edouard Belin, 5 1435 Mont-St-Guibert Belgium +32 10 46 10 10 Download Local Terms & Conditions Contact Us